Brachytherapy Seeds Market by Offerings (Radioactive Implants, Treatment Planning Software, Ultrasound Scanners, Accessories and Professional Training), by Isotopes (gold-198, iridium-192, iodine-125, cesium-131, Palladium and others) by Configurations (Loose, Stranded and Others); by Application (Prostate Cancer, Cervix, Head and Neck, Breast, Eye, Uterus, Vagina, Lung and Other Solid Tumors) by End Users (Hospitals, Specialty Centers and Others); By Region (U.S., Canada, Mexico, Rest of North America, UK, France, Germany, Italy, Spain, Benelux Union, Nordic Countries , Rest of Europe, China, Japan, India, South Korea, Southeast Asia, Australia, New Zealand, Rest of Asia Pacific) – North America, Europe and Asia Pacific Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2019 - 2027
Industry Trends
North America, Europe and Asia Pacific Brachytherapy Seeds market was valued at US$ 26,647.7 million in 2020 and is expected to reach US$ 60,680.5 million by 2028, growing at a CAGR of 8.7% over the forecast period. Brachytherapy is a form of radiation treatment for cancer, brachytherapy seeds is a small object comparable in size to a grain of rice. These seeds are placed around or within the tumour, the distance travelled by the radiation is short only affecting the desired area limiting damage to nearby areas of the body. Brachytherapy seeds has a number of advantages over other form of radiation therapies for treatment of cancer, these seeds limits tissue damage to surrounding healthy tissues, this is especially important in cancer patients as it restricts tissue damage to patients who are diagnosed with brain and prostate cancer. Brachytherapy is a cost effective therapy with very low chances of side effects than any other forms of radiation therapy, it is a less invasive procedure than surgical removal of tumour, because of this it has been a subject of a number of recent studies, many hospitals and doctors are using brachytherapy as a treatment option for cancer patients.
A major factor driving the growth of brachytherapy seeds market is the technological advances in brachytherapy, this treatment has advanced significantly in all areas which includes treatment planning, technology, patient selection amongst others. There are recent developments in brachytherapy treatment planning, this is due to development of new technologically advanced computer planning systems and delivery techniques. Three dimensional imaging modalities have been incorporated into treatment planning methods, also online planning has emerged to calculate and update dose distributions in real time by taking into consideration the actual clinical situation. These recent advancements are boosting the growth of brachytherapy market over the forecast period.
Increasing incidences of cancer is another factor which is fuelling the growth of brachytherapy seeds market. The number of patients diagnosed with cancer are increasing at a rapid rate, moreover there is an exponential increase in the number of patients who has brain cancer and prostate cancer. As treating brain cancer or prostate cancer requires precision and advanced techniques, brachytherapy seeds therapy is preferred by most of the patient as well as doctors to treat this type of cancer, as this therapy limits the tissue damage it is preferred by patients who are diagnosed with brain tumour. International Agency for research on cancer recently released a report which stated that more than 16 million people in the world are suffering from cancer and the number is anticipated to increase at a rapid rate over the years due to many factors. Treatment of this cancer with the help of brachytherapy is proving to be effective as this therapy is showing positive results with very less side effects, this will boost the market growth of brachytherapy seeds radiation treatment for cancer.
However high cost of the treatment is restraining the growth of the brachytherapy seeds market, also usage of this therapy is declining as clinicians are opting for flashier therapies. Clinicians are constantly finding alternatives to treat their patients, as there is a new therapy with recent technological advancements in the market hospitals and clinics quickly opt those to get better results this factor is confining the growth of this market, moreover there are some side effects associated with radiation like swelling, bleeding, bruising and pain this could hamper the use of these therapy.
Moreover, 3D imaging modalities are used in treatment of cervical cancer and also during treatment planning with high dose rates. 3D imaging has many benefits over 2D, 3D images used in treatment planning in high dose rates allows choosing the most appropriate method of treating with radiation, the seeds are planted on the affected area protecting critical organs around the affected area. 3D imaging is also used in the treatment of cervical cancer and thus have many applications in the while performing this treatment on patients, these factors are expected to boost the brachytherapy seeds market in the future.
Offerings Insights
The radioactive implants segment has the highest market and is also the fastest growing segment over the forecast period, radioactive implants are placed inside the patient to kill cancer cells and shrink tumours. With the help of internal radiation therapy the seeds are placed in the affected area, this therapy allows a higher dose of radiation in a smaller area. Different types of implants are used for treatment which includes seeds, pellets, ribbons, wires, balloons or tubes, whichever radioactive implant is used it is placed close or inside the tumour so that radiation harms as few normal cells as possible. The length of time for which these implants are placed depends on the on the type of brachytherapy the patient is getting and the type of implant depends on the type of cancer.
Isotopes Insights
Brachytherapy has a number of benefits over other forms of radiation therapy for cancer. This therapy offers the capability for specific treatment customization based on patient- needs and also allows for additional treatment options, brachytherapy seeds comes in different types and different isotopes. These isotopes are used for variation in intensities and half-life properties, isotopes have different radiation effects, also the distance it penetrates and time for which it is actively emitting radiation are also different for these isotopes. Iodine-125 has the highest market share over the forecast period, iodine-125 is effectively used in the treatment of patients diagnosed with prostate cancer and has higher efficiency. Moreover, cesium-131 is very effective in treatment of localized cancer, as the cesium-131 is placed inside the affected tumour it avoids collateral damage to other organs and tissues.
Configurations Insights
Some types of radioactive brachytherapy seeds implanted in patients to cure prostate cancer comes in either loose forms or stranded forms. Stranded or multi-seed forms has the highest market share and is the fastest growing segment over the forecast period, stranded seeds are used in curing prostate cancer by placing a series of 10 iodine-125 seeds on the affected area, these seeds are spaced precisely, also several other series are implanted into the prostate.
Application Insights
Prostate cancer has the highest market share over the forecast period; the number of people getting affected with prostate cancer is rising at a rapid rate across various countries. Prostate cancer is the most common cancer developed in men, the permanent seeds brachytherapy for prostate cancer has advanced significantly in all areas. Treatment planning technique and advanced technology has emitted positive results in treating prostate cancer also continuous efforts are being made to enhance the treatment technique for patients affected with the cancer. These advanced treatment techniques and products are helping target radiation dose to limit toxicity and improve quality of life.
End Users Insights
Brachytherapy is one of the best forms of radiation therapy for cancer, a high dosage of radiation to the tumour can be given with the help of this therapy with very minimal damage to the surrounding tissues. These advantages increases the chances of destroying the tumour reducing the risk to healthy tissues. Other radiation therapies requires 6-8 weeks for completion but brachytherapy requires just few days in order to deliver the course to the patient this reduces the time as well as many other resources of the patients. Hospital segment has the highest market share over the forecast period as hospitals are deploying these therapies due to its immense benefits.
Regional Insights
North America accounted for the highest market share in 2018 and is expected to continue the same trend over the forecast period. Countries in North America are widely using advanced techniques to cure cancer and there is an increasing adoption of brachytherapy technique as it is safer and efficient for cancer treatment. According to American Cancer Society, more than 2 million cancer patients will be diagnosed in United States, also the government is aiming to improve its healthcare reforms. Asia Pacific is the fastest growing market for brachytherapy as half of the people diagnosed with cancer are in the Asia Pacific region.
Brachytherapy Seeds Market Revenue & Forecast, (US$ Million), 2020 – 2028
Competitive Landscape
The report provides both, qualitative and quantitative research of brachytherapy seeds market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
The major market participants of brachytherapy seeds market include BD, BXTAccelyon Limited, Eckert & Ziegler, IsoAid, Isoray Inc., TeamBest, Theragenics Corporation and other market participants.
Brachytherapy Seeds Market:
By Offerings
- Radioactive Implants
- Treatment Planning Software
- Ultrasound Scanners
- Accessories
- Professional Training
By Isotopes
- gold-198
- iridium-192
- iodine-125
- cesium-131
- Palladium
- Others
By Configurations
- Loose
- Stranded
- Others
By Application
- Prostate Cancer
- Cervix
- Head and Neck
- Breast
- Eye
- Uterus
- Vagina
- Lung
- Other Solid Tumours
By End Users
- Hospitals
- Specialty Centers
- Others
By Geography
- North America
- US
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1. Market
Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2013 - 2017
1.2.2. Base
Year: 2018
1.2.3. Forecast
Years: 2019 – 2027
2. Key Target
Audiences
3. Research
Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations
and Insights from AMI’s Perspective**
5. Holistic
Overview of Brachytherapy Seeds Market
6. Market
Synopsis: Brachytherapy Seeds Market
7. Brachytherapy
Seeds Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market
Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Brachytherapy Seeds Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Brachytherapy Seeds Market
7.6. Porter’s
Five Force Analysis
8. North
America Brachytherapy Seeds Market Analysis and Forecasts, 2019 - 2027
8.1. Overview
8.1.1. North
America Brachytherapy Seeds Market Revenue (US$ Mn)
8.2. North
America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
8.2.1. Radioactive
Implants
8.2.2. Treatment
Planning Software
8.2.3. Ultrasound
Scanners
8.2.4. Accessories
8.2.5. Professional
Training
8.3. North
America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
8.3.1. gold-198
8.3.2. iridium-192
8.3.3. iodine-125
8.3.4. cesium-131
8.3.5. Palladium
8.3.6. Others
8.4. North
America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
8.4.1. Loose
8.4.2. Cervix
8.4.3. Head and
Neck
8.4.4. Breast
8.4.5. Eye
8.4.6. Uterus
8.4.7. Vagina
8.4.8. Lung
8.4.9. Other
Solid Tumours
8.5. North
America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
8.5.1. Hospitals
8.5.2. Specialty
Centers
8.5.3. Others
8.6. North
America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Country
8.6.1. U.S
8.6.1.1. U.S
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
8.6.1.1.1. Radioactive
Implants
8.6.1.1.2. Treatment
Planning Software
8.6.1.1.3. Ultrasound
Scanners
8.6.1.1.4. Accessories
8.6.1.1.5. Professional
Training
8.6.1.2. U.S
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
8.6.1.2.1. gold-198
8.6.1.2.2. iridium-192
8.6.1.2.3. iodine-125
8.6.1.2.4. cesium-131
8.6.1.2.5. Palladium
8.6.1.2.6. Others
8.6.1.3. U.S
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
8.6.1.3.1. Loose
8.6.1.3.2. Cervix
8.6.1.3.3. Head
and Neck
8.6.1.3.4. Breast
8.6.1.3.5. Eye
8.6.1.3.6. Uterus
8.6.1.3.7. Vagina
8.6.1.3.8. Lung
8.6.1.3.9. Other
Solid Tumours
8.6.1.4. U.S
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
8.6.1.4.1. Hospitals
8.6.1.4.2. Specialty
Centers
8.6.1.4.3. Others
8.6.2. Canada
8.6.2.1. Canada
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
8.6.2.1.1. Radioactive
Implants
8.6.2.1.2. Treatment
Planning Software
8.6.2.1.3. Ultrasound
Scanners
8.6.2.1.4. Accessories
8.6.2.1.5. Professional
Training
8.6.2.2. Canada
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
8.6.2.2.1. gold-198
8.6.2.2.2. iridium-192
8.6.2.2.3. iodine-125
8.6.2.2.4. cesium-131
8.6.2.2.5. Palladium
8.6.2.2.6. Others
8.6.2.3. Canada
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
8.6.2.3.1. Loose
8.6.2.3.2. Cervix
8.6.2.3.3. Head
and Neck
8.6.2.3.4. Breast
8.6.2.3.5. Eye
8.6.2.3.6. Uterus
8.6.2.3.7. Vagina
8.6.2.3.8. Lung
8.6.2.3.9. Other
Solid Tumours
8.6.2.4. Canada
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
8.6.2.4.1. Hospitals
8.6.2.4.2. Specialty
Centers
8.6.2.4.3. Others
8.6.3. Mexico
8.6.3.1. Mexico
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
8.6.3.1.1. Radioactive
Implants
8.6.3.1.2. Treatment
Planning Software
8.6.3.1.3. Ultrasound
Scanners
8.6.3.1.4. Accessories
8.6.3.1.5. Professional
Training
8.6.3.2. Mexico
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
8.6.3.2.1. gold-198
8.6.3.2.2. iridium-192
8.6.3.2.3. iodine-125
8.6.3.2.4. cesium-131
8.6.3.2.5. Palladium
8.6.3.2.6. Others
8.6.3.3. Mexico
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
8.6.3.3.1. Loose
8.6.3.3.2. Cervix
8.6.3.3.3. Head
and Neck
8.6.3.3.4. Breast
8.6.3.3.5. Eye
8.6.3.3.6. Uterus
8.6.3.3.7. Vagina
8.6.3.3.8. Lung
8.6.3.3.9. Other
Solid Tumours
8.6.3.4. Mexico
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
8.6.3.4.1. Hospitals
8.6.3.4.2. Specialty
Centers
8.6.3.4.3. Others
8.6.4. Rest of
North America
8.6.4.1. Rest
of North America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Offerings
8.6.4.1.1. Radioactive
Implants
8.6.4.1.2. Treatment
Planning Software
8.6.4.1.3. Ultrasound
Scanners
8.6.4.1.4. Accessories
8.6.4.1.5. Professional
Training
8.6.4.2. Rest
of North America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Isotopes
8.6.4.2.1. gold-198
8.6.4.2.2. iridium-192
8.6.4.2.3. iodine-125
8.6.4.2.4. cesium-131
8.6.4.2.5. Palladium
8.6.4.2.6. Others
8.6.4.3. Rest
of North America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
8.6.4.3.1. Loose
8.6.4.3.2. Cervix
8.6.4.3.3. Head
and Neck
8.6.4.3.4. Breast
8.6.4.3.5. Eye
8.6.4.3.6. Uterus
8.6.4.3.7. Vagina
8.6.4.3.8. Lung
8.6.4.3.9. Other
Solid Tumours
8.6.4.4. Rest
of North America Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
End Users
8.6.4.4.1. Hospitals
8.6.4.4.2. Specialty
Centers
8.6.4.4.3. Others
8.7. Key
Segment for Channeling Investments
8.7.1. By
Country
8.7.2. By
Offerings
8.7.3. By
Isotopes
8.7.4. By
Configurations
8.7.5. By End
Users
9. Europe
Brachytherapy Seeds Market Analysis and Forecasts, 2019 - 2027
9.1. Overview
9.1.1. Europe
Brachytherapy Seeds Market Revenue (US$ Mn)
9.2. Europe
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.2.1. Radioactive
Implants
9.2.2. Treatment
Planning Software
9.2.3. Ultrasound
Scanners
9.2.4. Accessories
9.2.5. Professional
Training
9.3. Europe
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.3.1. gold-198
9.3.2. iridium-192
9.3.3. iodine-125
9.3.4. cesium-131
9.3.5. Palladium
9.3.6. Others
9.4. Europe
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
9.4.1. Loose
9.4.2. Cervix
9.4.3. Head and
Neck
9.4.4. Breast
9.4.5. Eye
9.4.6. Uterus
9.4.7. Vagina
9.4.8. Lung
9.4.9. Other
Solid Tumours
9.5. Europe
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.5.1. Hospitals
9.5.2. Specialty
Centers
9.5.3. Others
9.6. Europe
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Country
9.6.1. France
9.6.1.1. France
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.6.1.1.1. Radioactive
Implants
9.6.1.1.2. Treatment
Planning Software
9.6.1.1.3. Ultrasound
Scanners
9.6.1.1.4. Accessories
9.6.1.1.5. Professional
Training
9.6.1.2. France
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.6.1.2.1. gold-198
9.6.1.2.2. iridium-192
9.6.1.2.3. iodine-125
9.6.1.2.4. cesium-131
9.6.1.2.5. Palladium
9.6.1.2.6. Others
9.6.1.3. France
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
9.6.1.3.1. Loose
9.6.1.3.2. Cervix
9.6.1.3.3. Head
and Neck
9.6.1.3.4. Breast
9.6.1.3.5. Eye
9.6.1.3.6. Uterus
9.6.1.3.7. Vagina
9.6.1.3.8. Lung
9.6.1.3.9. Other
Solid Tumours
9.6.1.4. France
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.6.1.4.1. Hospitals
9.6.1.4.2. Specialty
Centers
9.6.1.4.3. Others
9.6.2. The UK
9.6.2.1. The UK
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.6.2.1.1. Radioactive
Implants
9.6.2.1.2. Treatment
Planning Software
9.6.2.1.3. Ultrasound
Scanners
9.6.2.1.4. Accessories
9.6.2.1.5. Professional
Training
9.6.2.2. The UK
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.6.2.2.1. gold-198
9.6.2.2.2. iridium-192
9.6.2.2.3. iodine-125
9.6.2.2.4. cesium-131
9.6.2.2.5. Palladium
9.6.2.2.6. Others
9.6.2.3. The UK
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
9.6.2.3.1. Loose
9.6.2.3.2. Cervix
9.6.2.3.3. Head
and Neck
9.6.2.3.4. Breast
9.6.2.3.5. Eye
9.6.2.3.6. Uterus
9.6.2.3.7. Vagina
9.6.2.3.8. Lung
9.6.2.3.9. Other
Solid Tumours
9.6.2.4. The UK
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.6.2.4.1. Hospitals
9.6.2.4.2. Specialty
Centers
9.6.2.4.3. Others
9.6.3. Spain
9.6.3.1. Spain
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.6.3.1.1. Radioactive
Implants
9.6.3.1.2. Treatment
Planning Software
9.6.3.1.3. Ultrasound
Scanners
9.6.3.1.4. Accessories
9.6.3.1.5. Professional
Training
9.6.3.2. Spain
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.6.3.2.1. gold-198
9.6.3.2.2. iridium-192
9.6.3.2.3. iodine-125
9.6.3.2.4. cesium-131
9.6.3.2.5. Palladium
9.6.3.2.6. Others
9.6.3.3. Spain
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
9.6.3.3.1. Loose
9.6.3.3.2. Cervix
9.6.3.3.3. Head
and Neck
9.6.3.3.4. Breast
9.6.3.3.5. Eye
9.6.3.3.6. Uterus
9.6.3.3.7. Vagina
9.6.3.3.8. Lung
9.6.3.3.9. Other
Solid Tumours
9.6.3.4. Spain
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.6.3.4.1. Hospitals
9.6.3.4.2. Specialty
Centers
9.6.3.4.3. Others
9.6.4. Germany
9.6.4.1. Germany
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.6.4.1.1. Radioactive
Implants
9.6.4.1.2. Treatment
Planning Software
9.6.4.1.3. Ultrasound
Scanners
9.6.4.1.4. Accessories
9.6.4.1.5. Professional
Training
9.6.4.2. Germany
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.6.4.2.1. gold-198
9.6.4.2.2. iridium-192
9.6.4.2.3. iodine-125
9.6.4.2.4. cesium-131
9.6.4.2.5. Palladium
9.6.4.2.6. Others
9.6.4.3. Germany
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
9.6.4.3.1. Loose
9.6.4.3.2. Cervix
9.6.4.3.3. Head
and Neck
9.6.4.3.4. Breast
9.6.4.3.5. Eye
9.6.4.3.6. Uterus
9.6.4.3.7. Vagina
9.6.4.3.8. Lung
9.6.4.3.9. Other
Solid Tumours
9.6.4.4. Germany
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.6.4.4.1. Hospitals
9.6.4.4.2. Specialty
Centers
9.6.4.4.3. Others
9.6.5. Italy
9.6.5.1. Italy
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.6.5.1.1. Radioactive
Implants
9.6.5.1.2. Treatment
Planning Software
9.6.5.1.3. Ultrasound
Scanners
9.6.5.1.4. Accessories
9.6.5.1.5. Professional
Training
9.6.5.2. Italy
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.6.5.2.1. gold-198
9.6.5.2.2. iridium-192
9.6.5.2.3. iodine-125
9.6.5.2.4. cesium-131
9.6.5.2.5. Palladium
9.6.5.2.6. Others
9.6.5.3. Italy
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
9.6.5.3.1. Loose
9.6.5.3.2. Cervix
9.6.5.3.3. Head
and Neck
9.6.5.3.4. Breast
9.6.5.3.5. Eye
9.6.5.3.6. Uterus
9.6.5.3.7. Vagina
9.6.5.3.8. Lung
9.6.5.3.9. Other
Solid Tumours
9.6.5.4. Italy
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.6.5.4.1. Hospitals
9.6.5.4.2. Specialty
Centers
9.6.5.4.3. Others
9.6.6. Nordic
Countries
9.6.6.1. Nordic
Countries Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Offerings
9.6.6.1.1. Radioactive
Implants
9.6.6.1.2. Treatment
Planning Software
9.6.6.1.3. Ultrasound
Scanners
9.6.6.1.4. Accessories
9.6.6.1.5. Professional
Training
9.6.6.2. Nordic
Countries Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Isotopes
9.6.6.2.1. gold-198
9.6.6.2.2. iridium-192
9.6.6.2.3. iodine-125
9.6.6.2.4. cesium-131
9.6.6.2.5. Palladium
9.6.6.2.6. Others
9.6.6.3. Nordic
Countries Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
9.6.6.3.1. Loose
9.6.6.3.2. Cervix
9.6.6.3.3. Head
and Neck
9.6.6.3.4. Breast
9.6.6.3.5. Eye
9.6.6.3.6. Uterus
9.6.6.3.7. Vagina
9.6.6.3.8. Lung
9.6.6.3.9. Other
Solid Tumours
9.6.6.4. Nordic
Countries Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End
Users
9.6.6.4.1. Hospitals
9.6.6.4.2. Specialty
Centers
9.6.6.4.3. Others
9.6.6.5. Nordic
Countries Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Country
9.6.6.5.1. Denmark
9.6.6.5.2. Finland
9.6.6.5.3. Iceland
9.6.6.5.4. Sweden
9.6.6.5.5. Norway
9.6.7. Benelux
Union
9.6.7.1. Benelux
Union Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
9.6.7.1.1. Radioactive
Implants
9.6.7.1.2. Treatment
Planning Software
9.6.7.1.3. Ultrasound
Scanners
9.6.7.1.4. Accessories
9.6.7.1.5. Professional
Training
9.6.7.2. Benelux
Union Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
9.6.7.2.1. gold-198
9.6.7.2.2. iridium-192
9.6.7.2.3. iodine-125
9.6.7.2.4. cesium-131
9.6.7.2.5. Palladium
9.6.7.2.6. Others
9.6.7.3. Benelux
Union Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
9.6.7.3.1. Loose
9.6.7.3.2. Cervix
9.6.7.3.3. Head
and Neck
9.6.7.3.4. Breast
9.6.7.3.5. Eye
9.6.7.3.6. Uterus
9.6.7.3.7. Vagina
9.6.7.3.8. Lung
9.6.7.3.9. Other
Solid Tumours
9.6.7.4. Benelux
Union Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
9.6.7.4.1. Hospitals
9.6.7.4.2. Specialty
Centers
9.6.7.4.3. Others
9.6.7.5. Benelux
Union Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Country
9.6.7.5.1. Belgium
9.6.7.5.2. The
Netherlands
9.6.7.5.3. Luxembourg
9.6.8. Rest of
Europe
9.6.8.1. Rest
of Europe Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Offerings
9.6.8.1.1. Radioactive
Implants
9.6.8.1.2. Treatment
Planning Software
9.6.8.1.3. Ultrasound
Scanners
9.6.8.1.4. Accessories
9.6.8.1.5. Professional
Training
9.6.8.2. Rest
of Europe Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Isotopes
9.6.8.2.1. gold-198
9.6.8.2.2. iridium-192
9.6.8.2.3. iodine-125
9.6.8.2.4. cesium-131
9.6.8.2.5. Palladium
9.6.8.2.6. Others
9.6.8.3. Rest
of Europe Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
9.6.8.3.1. Loose
9.6.8.3.2. Cervix
9.6.8.3.3. Head
and Neck
9.6.8.3.4. Breast
9.6.8.3.5. Eye
9.6.8.3.6. Uterus
9.6.8.3.7. Vagina
9.6.8.3.8. Lung
9.6.8.3.9. Other
Solid Tumours
9.6.8.4. Rest
of Europe Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End
Users
9.6.8.4.1. Hospitals
9.6.8.4.2. Specialty
Centers
9.6.8.4.3. Others
9.7. Key
Segment for Channeling Investments
9.7.1. By
Country
9.7.2. By
Offerings
9.7.3. By
Isotopes
9.7.4. By
Configurations
9.7.5. By End
Users
10. Asia
Pacific Brachytherapy Seeds Market Analysis and Forecasts, 2019 - 2027
10.1. Overview
10.1.1. Asia
Pacific Brachytherapy Seeds Market Revenue (US$ Mn)
10.2. Asia
Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.2.1. Radioactive
Implants
10.2.2. Treatment
Planning Software
10.2.3. Ultrasound
Scanners
10.2.4. Accessories
10.2.5. Professional
Training
10.3. Asia
Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.3.1. gold-198
10.3.2. iridium-192
10.3.3. iodine-125
10.3.4. cesium-131
10.3.5. Palladium
10.3.6. Others
10.4. Asia
Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
10.4.1. Loose
10.4.2. Cervix
10.4.3. Head
and Neck
10.4.4. Breast
10.4.5. Eye
10.4.6. Uterus
10.4.7. Vagina
10.4.8. Lung
10.4.9. Other
Solid Tumours
10.5. Asia
Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.5.1. Hospitals
10.5.2. Specialty
Centers
10.5.3. Others
10.6. Asia
Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Country
10.6.1. China
10.6.1.1. China
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.1.1.1. Radioactive
Implants
10.6.1.1.2. Treatment
Planning Software
10.6.1.1.3. Ultrasound
Scanners
10.6.1.1.4. Accessories
10.6.1.1.5. Professional
Training
10.6.1.2. China
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.1.2.1. gold-198
10.6.1.2.2. iridium-192
10.6.1.2.3. iodine-125
10.6.1.2.4. cesium-131
10.6.1.2.5. Palladium
10.6.1.2.6. Others
10.6.1.3. China
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
10.6.1.3.1. Loose
10.6.1.3.2. Cervix
10.6.1.3.3. Head
and Neck
10.6.1.3.4. Breast
10.6.1.3.5. Eye
10.6.1.3.6. Uterus
10.6.1.3.7. Vagina
10.6.1.3.8. Lung
10.6.1.3.9. Other
Solid Tumours
10.6.1.4. China
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.1.4.1. Hospitals
10.6.1.4.2. Specialty
Centers
10.6.1.4.3. Others
10.6.2. Japan
10.6.2.1. Japan
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.2.1.1. Radioactive
Implants
10.6.2.1.2. Treatment
Planning Software
10.6.2.1.3. Ultrasound
Scanners
10.6.2.1.4. Accessories
10.6.2.1.5. Professional
Training
10.6.2.2. Japan
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.2.2.1. gold-198
10.6.2.2.2. iridium-192
10.6.2.2.3. iodine-125
10.6.2.2.4. cesium-131
10.6.2.2.5. Palladium
10.6.2.2.6. Others
10.6.2.3. Japan
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
10.6.2.3.1. Loose
10.6.2.3.2. Cervix
10.6.2.3.3. Head
and Neck
10.6.2.3.4. Breast
10.6.2.3.5. Eye
10.6.2.3.6. Uterus
10.6.2.3.7. Vagina
10.6.2.3.8. Lung
10.6.2.3.9. Other
Solid Tumours
10.6.2.4. Japan
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.2.4.1. Hospitals
10.6.2.4.2. Specialty
Centers
10.6.2.4.3. Others
10.6.3. India
10.6.3.1. India
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.3.1.1. Radioactive
Implants
10.6.3.1.2. Treatment
Planning Software
10.6.3.1.3. Ultrasound
Scanners
10.6.3.1.4. Accessories
10.6.3.1.5. Professional
Training
10.6.3.2. India
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.3.2.1. gold-198
10.6.3.2.2. iridium-192
10.6.3.2.3. iodine-125
10.6.3.2.4. cesium-131
10.6.3.2.5. Palladium
10.6.3.2.6. Others
10.6.3.3. India
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
10.6.3.3.1. Loose
10.6.3.3.2. Cervix
10.6.3.3.3. Head
and Neck
10.6.3.3.4. Breast
10.6.3.3.5. Eye
10.6.3.3.6. Uterus
10.6.3.3.7. Vagina
10.6.3.3.8. Lung
10.6.3.3.9. Other
Solid Tumours
10.6.3.4. India
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.3.4.1. Hospitals
10.6.3.4.2. Specialty
Centers
10.6.3.4.3. Others
10.6.4. New
Zealand
10.6.4.1. New
Zealand Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.4.1.1. Radioactive
Implants
10.6.4.1.2. Treatment
Planning Software
10.6.4.1.3. Ultrasound
Scanners
10.6.4.1.4. Accessories
10.6.4.1.5. Professional
Training
10.6.4.2. New
Zealand Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.4.2.1. gold-198
10.6.4.2.2. iridium-192
10.6.4.2.3. iodine-125
10.6.4.2.4. cesium-131
10.6.4.2.5. Palladium
10.6.4.2.6. Others
10.6.4.3. New
Zealand Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
10.6.4.3.1. Loose
10.6.4.3.2. Cervix
10.6.4.3.3. Head
and Neck
10.6.4.3.4. Breast
10.6.4.3.5. Eye
10.6.4.3.6. Uterus
10.6.4.3.7. Vagina
10.6.4.3.8. Lung
10.6.4.3.9. Other
Solid Tumours
10.6.4.4. New
Zealand Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.4.4.1. Hospitals
10.6.4.4.2. Specialty
Centers
10.6.4.4.3. Others
10.6.5. Australia
10.6.5.1. Australia
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.5.1.1. Radioactive
Implants
10.6.5.1.2. Treatment
Planning Software
10.6.5.1.3. Ultrasound
Scanners
10.6.5.1.4. Accessories
10.6.5.1.5. Professional
Training
10.6.5.2. Australia
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.5.2.1. gold-198
10.6.5.2.2. iridium-192
10.6.5.2.3. iodine-125
10.6.5.2.4. cesium-131
10.6.5.2.5. Palladium
10.6.5.2.6. Others
10.6.5.3. Australia
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Configurations
10.6.5.3.1. Loose
10.6.5.3.2. Cervix
10.6.5.3.3. Head
and Neck
10.6.5.3.4. Breast
10.6.5.3.5. Eye
10.6.5.3.6. Uterus
10.6.5.3.7. Vagina
10.6.5.3.8. Lung
10.6.5.3.9. Other
Solid Tumours
10.6.5.4. Australia
Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.5.4.1. Hospitals
10.6.5.4.2. Specialty
Centers
10.6.5.4.3. Others
10.6.6. South
Korea
10.6.6.1. South
Korea Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.6.1.1. Radioactive
Implants
10.6.6.1.2. Treatment
Planning Software
10.6.6.1.3. Ultrasound
Scanners
10.6.6.1.4. Accessories
10.6.6.1.5. Professional
Training
10.6.6.2. South
Korea Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.6.2.1. gold-198
10.6.6.2.2. iridium-192
10.6.6.2.3. iodine-125
10.6.6.2.4. cesium-131
10.6.6.2.5. Palladium
10.6.6.2.6. Others
10.6.6.3. South
Korea Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
10.6.6.3.1. Loose
10.6.6.3.2. Cervix
10.6.6.3.3. Head
and Neck
10.6.6.3.4. Breast
10.6.6.3.5. Eye
10.6.6.3.6. Uterus
10.6.6.3.7. Vagina
10.6.6.3.8. Lung
10.6.6.3.9. Other
Solid Tumours
10.6.6.4. South
Korea Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.6.4.1. Hospitals
10.6.6.4.2. Specialty
Centers
10.6.6.4.3. Others
10.6.7. Southeast
Asia
10.6.7.1. Southeast
Asia Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Offerings
10.6.7.1.1. Radioactive
Implants
10.6.7.1.2. Treatment
Planning Software
10.6.7.1.3. Ultrasound
Scanners
10.6.7.1.4. Accessories
10.6.7.1.5. Professional
Training
10.6.7.2. Southeast
Asia Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Isotopes
10.6.7.2.1. gold-198
10.6.7.2.2. iridium-192
10.6.7.2.3. iodine-125
10.6.7.2.4. cesium-131
10.6.7.2.5. Palladium
10.6.7.2.6. Others
10.6.7.3. Southeast
Asia Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
10.6.7.3.1. Loose
10.6.7.3.2. Cervix
10.6.7.3.3. Head
and Neck
10.6.7.3.4. Breast
10.6.7.3.5. Eye
10.6.7.3.6. Uterus
10.6.7.3.7. Vagina
10.6.7.3.8. Lung
10.6.7.3.9. Other
Solid Tumours
10.6.7.4. Southeast
Asia Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By End Users
10.6.7.4.1. Hospitals
10.6.7.4.2. Specialty
Centers
10.6.7.4.3. Others
10.6.7.5. Southeast
Asia Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By Country
10.6.7.5.1. Indonesia
10.6.7.5.2. Thailand
10.6.7.5.3. Malaysia
10.6.7.5.4. Singapore
10.6.7.5.5. Rest
of Southeast Asia
10.6.8. Rest of
Asia Pacific
10.6.8.1. Rest
of Asia Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Offerings
10.6.8.1.1. Radioactive
Implants
10.6.8.1.2. Treatment
Planning Software
10.6.8.1.3. Ultrasound
Scanners
10.6.8.1.4. Accessories
10.6.8.1.5. Professional
Training
10.6.8.2. Rest
of Asia Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Isotopes
10.6.8.2.1. gold-198
10.6.8.2.2. iridium-192
10.6.8.2.3. iodine-125
10.6.8.2.4. cesium-131
10.6.8.2.5. Palladium
10.6.8.2.6. Others
10.6.8.3. Rest
of Asia Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
Configurations
10.6.8.3.1. Loose
10.6.8.3.2. Cervix
10.6.8.3.3. Head
and Neck
10.6.8.3.4. Breast
10.6.8.3.5. Eye
10.6.8.3.6. Uterus
10.6.8.3.7. Vagina
10.6.8.3.8. Lung
10.6.8.3.9. Other
Solid Tumours
10.6.8.4. Rest
of Asia Pacific Brachytherapy Seeds Market Revenue (US$ Mn) and Forecasts, By
End Users
10.6.8.4.1. Hospitals
10.6.8.4.2. Specialty
Centers
10.6.8.4.3. Others
10.7. Key
Segment for Channeling Investments
10.7.1. By
Country
10.7.2. By
Offerings
10.7.3. By Isotopes
10.7.4. By
Configurations
10.7.5. By End
Users
11. Competitive
Benchmarking
11.1. Market
Share Analysis, 2018
11.2. North
America, Europe and Asia Pacific Presence and Growth Strategies
11.2.1. Mergers
and Acquisitions
11.2.2. Product
Launches
11.2.3. Investments
Trends
11.2.4. R&D
Initiatives
12. Player
Profiles
12.1. BD
12.1.1. Company
Details
12.1.2. Company
Overview
12.1.3. Product
Offerings
12.1.4. Key
Developments
12.1.5. Financial
Analysis
12.1.6. SWOT
Analysis
12.1.7. Business
Strategies
12.2. BXTAccelyon
Limited
12.2.1. Company
Details
12.2.2. Company
Overview
12.2.3. Product
Offerings
12.2.4. Key
Developments
12.2.5. Financial
Analysis
12.2.6. SWOT
Analysis
12.2.7. Business
Strategies
12.3. Eckert
and Ziegler
12.3.1. Company
Details
12.3.2. Company
Overview
12.3.3. Product
Offerings
12.3.4. Key
Developments
12.3.5. Financial
Analysis
12.3.6. SWOT
Analysis
12.3.7. Business
Strategies
12.4. IsoAid
12.4.1. Company
Details
12.4.2. Company
Overview
12.4.3. Product
Offerings
12.4.4. Key
Developments
12.4.5. Financial
Analysis
12.4.6. SWOT
Analysis
12.4.7. Business
Strategies
12.5. Isoray
Inc.
12.5.1. Company
Details
12.5.2. Company
Overview
12.5.3. Product
Offerings
12.5.4. Key
Developments
12.5.5. Financial
Analysis
12.5.6. SWOT
Analysis
12.5.7. Business
Strategies
12.6. TeamBest
12.6.1. Company
Details
12.6.2. Company
Overview
12.6.3. Product
Offerings
12.6.4. Key
Developments
12.6.5. Financial
Analysis
12.6.6. SWOT Analysis
12.6.7. Business
Strategies
12.7. Theragenics
Corporation
12.7.1. Company
Details
12.7.2. Company
Overview
12.7.3. Product
Offerings
12.7.4. Key
Developments
12.7.5. Financial
Analysis
12.7.6. SWOT
Analysis
12.7.7. Business
Strategies
12.8. Other
Market Participants
13. Key
Findings
Note: This ToC is tentative and can
be changed according to the research study conducted during the course of
report completion.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
